Division of Pharmacognostical Biotechnology, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.
Phytochemistry. 2009 Jul-Aug;70(11-12):1416-20. doi: 10.1016/j.phytochem.2009.07.041. Epub 2009 Sep 3.
Biotransformation of 20(S)-protopanaxadiol (1) by the fungus Mucor spinosus AS 3.3450 yielded eight metabolites (2-9). On the basis of NMR and MS analyses, the metabolites were identified as 12-oxo-15alpha,27-dihydroxyl-20(S)-protopanaxadiol (2), 12-oxo-7beta,11alpha,28-trihydroxyl-20(S)-protopanaxadiol (3), 12-oxo-7beta,28-dihydroxyl-20(S)-protopanaxadiol (4), 12-oxo-15alpha,29-dihydroxyl-20(S)-protopanaxadiol (5), 12-oxo-7beta,15alpha-dihydroxyl-20(S)-protopanaxadiol (6), 12-oxo-7beta,11beta-dihydroxyl-20(S)-protopanaxadiol (7), 12-oxo-15alpha-hydroxyl-20(S)-protopanaxadiol (8), and 12-oxo-7beta-hydroxyl-20(S)-protopanaxadiol (9), respectively. Among them, 2-5, 7, and 8 are new compounds. These results indicated that M. spinosus could catalyze the specific C-12 dehydrogenation of 20(S)-protopanaxadiol, as well hydroxylation at different positions. These biocatalytic reactions may be difficult for chemical synthesis. The biotransformed products showed weak in vitro cytotoxic activities.
真菌棘孢木霉 AS 3.3450 生物转化 20(S)-原人参二醇(1)生成了 8 种代谢产物(2-9)。基于 NMR 和 MS 分析,鉴定这些代谢产物为 12-酮-15α,27-二羟基-20(S)-原人参二醇(2)、12-酮-7β,11α,28-三羟基-20(S)-原人参二醇(3)、12-酮-7β,28-二羟基-20(S)-原人参二醇(4)、12-酮-15α,29-二羟基-20(S)-原人参二醇(5)、12-酮-7β,15α-二羟基-20(S)-原人参二醇(6)、12-酮-7β,11β-二羟基-20(S)-原人参二醇(7)、12-酮-15α-羟基-20(S)-原人参二醇(8)和 12-酮-7β-羟基-20(S)-原人参二醇(9)。其中 2-5、7 和 8 是新化合物。这些结果表明棘孢木霉能够特异性地催化 20(S)-原人参二醇的 C-12 脱氢以及不同位置的羟化反应。这些生物催化反应可能难以通过化学合成实现。生物转化产物显示出较弱的体外细胞毒性活性。